SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

iStreet Network informs about outcome of board meeting

29 Jan 2022 Evaluate

In accordance with the provisions or SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), iStreet Network has informed that the outcome of the meeting of the Board of Directors of the Company held today 28th January 2022 at 04.00 pm which concluded at 05.15 pm. The meeting transacted the following business: Approved the issue of 70 lakhs Equity Warrants on Preferential basis to Nixel Technology subject to the approval of the Shareholders of the company in the forthcoming Extra Ordinary General Meeting, Approved the alteration of the Main Object clause of the Memorandum of Association of the company by adding clauses related to the new business, subject to the approval of the Shareholders of the company in the forthcoming Extra Ordinary General Meeting, Approved the proposal to convene the Extra Ordinary General Meeting of the shareholders on Thursday, 24th February 2022, at 11.00 am through Video Conferencing (VC) / Other Audio Visual Means (OAVM), and approved the draft notice of Extra Ordinary General Meeting, Approved the appointment of Neha Poddar, Practicing Company Secretary to act as scrutinizer for the remote e-voting process at the ensuing Extra Ordinary General meeting, Approved the appointment of Independent Chartered Accountant/ Independent auditor to obtain the necessary certificate with respect to the issue of warrants for equity shares on preferential basis to Nixel Technology and The Register of Members and Share transfer Books of the Company will remain closed from Saturday 19th February 2022 to Thursday, 24th February 2022 for the purpose of the Extra Ordinary General Meeting of the Company.

The above information is a part of company’s filings submitted to BSE.

iStreet Network Share Price

51.69 -0.15 (-0.29%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×